Democrats' Last Chance for Drug Pricing Reform?

Virtual
July 20 at 1 p.m. ET / 10 a.m. PT

Once again Congress is barreling towards drug pricing reform. STAT will sit down with key decision makers to talk about the latest developments from Capitol Hill and the White House.

Part 1: Listening to the Experts

• Rena Conti, Ph.D., associate professor, Department of Markets, Public Policy and Law, Questrom School of Business, Boston University
• Stacie B. Dusetzina, Ph.D., associate professor of health policy, Ingram associate professor of cancer research, Vanderbilt University School of Medicine
• Richard G. Frank, Ph.D., director of the USC-Brookings Schaeffer Initiative on Health Policy; fellow in economic studies; Margaret T. Morris professor of health economics, emeritus, department of health care policy, Harvard Medical School
• Rachel Cohrs, Washington correspondent, STAT (moderator)

• Sen. Ron Wyden (D-Ore.), Chairman of the Senate Finance Committee
• Rachel Cohrs, Washington correspondent, STAT (moderator)